# AbbVie Inc. (ABBV) — Q3-2025 Earnings Results

**Report date:** 2025-10-31 (before market open)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/ABBV/earnings/Q3-2025

## Post-Earnings Brief

### Headline

AbbVie Beats on EPS, Stock Down 4.45%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.86 | N/A | +4.91% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management expressed a cautious optimism about the company's performance. They emphasized their commitment to navigating market challenges.

**Key quotes:**

> Management highlighted the continued strength in their core products.

> They acknowledged challenges in the market but remain focused on long-term growth.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

AbbVie's earnings report showed a positive surprise in EPS, indicating better-than-expected profitability. However, the stock fell by 4.45%, likely due to investor concerns about revenue performance and market challenges. The lack of guidance may have also contributed to the negative stock reaction, as investors often look for future direction from management.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/ABBV/earnings/Q3-2025_